SEARCH
Covaxin Vaccine: 2 ते 18 वयोगटावर कोवॅक्सिनची चाचणी करण्यास DCGI कडून Bharat Biotechला परवानगी
LatestLY Marathi
2021-05-13
Views
55
Description
Share / Embed
Download This Video
Report
भारत बायोटेकची कोविड-19 लस 2-18 वयोगटातील मुलांवर चाचणी करण्यास DCGI ची परवानगी मिळाली आहे. त्यानंतर आता दुसऱ्या आणि तिसऱ्या टप्प्यातील क्लिनिकल ट्रायल्स (Clinical Trials) करण्यात येतील.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x81999w" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:20
COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By DCGI
02:20
COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By The Drugs Controller General Of India (DCGI)
01:35
Bharat Biotech Submits Covaxin Phase-III Clinical Trial Data To DCGI
03:55
भारत बायोटेकच्या लसीची मुंबईत चाचणी | Bharat Biotech Covaxin Test In Mumbai | Maharshtra News
07:03
Covid vaccine: DCGI approves Serum, Bharat Biotech vaccines for emergency use
05:29
COVID-19 Vaccine Update: Sputnik V To Undergo Trial In India, Dr Reddys Gets DCGI Approval, Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials
04:12
Corona Nasal Vaccine: Bharat Biotech की Nasal Vaccine को DCGI से मिली मंजूरी | वनइंडिया हिंदी *News
02:54
Bharat Biotech Concludes Final Analysis For Covaxin Efficacy | Covaxin News | Covid Vaccine
04:09
India Approves Two COVID-19 Vaccines: Oxford-Serum Institute's Covishield & Bharat Biotech's Covaxin Receives Emergency Approval From DCGI
04:00
भारत में होगा Covid19 Vaccine का फेज-3 ट्रायल, Bharat BioTech को मिला जिम्मा | Covaxin Vaccine India
03:02
Decision On Bharat Biotechs Vaccine Candidate For Children | Know Details
09:34
OTV Debate On Bharat Biotechs Vaccine Candidate For Children | WATCH